%0 Journal Article %1 citeulike:14558375 %A White, William B. %A Saag, Kenneth G. %A Becker, Michael A. %A Borer, Jeffrey S. %A Gorelick, Philip B. %A Whelton, Andrew %A Hunt, Barbara %A Castillo, Majin %A Gunawardhana, Lhanoo %D 2018 %I Massachusetts Medical Society %J N Engl J Med %K citeulikeExport exampearl, rheumatology %N 13 %P 1200--1210 %R 10.1056/nejmoa1710895 %T Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout %U http://dx.doi.org/10.1056/nejmoa1710895 %V 378 %X Cardiovascular Safety of Febuxostat Patients with gout and cardiovascular disease were assigned to receive febuxostat or allopurinol. At 32 months, there was no significant between-group difference in a composite cardiovascular end point, but all-cause and cardiovascular mortality were higher with febuxostat.

@article{citeulike:14558375, abstract = {{Cardiovascular Safety of Febuxostat Patients with gout and cardiovascular disease were assigned to receive febuxostat or allopurinol. At 32 months, there was no significant between-group difference in a composite cardiovascular end point, but all-cause and cardiovascular mortality were higher with febuxostat.}}, added-at = {2019-03-31T01:14:40.000+0100}, author = {White, William B. and Saag, Kenneth G. and Becker, Michael A. and Borer, Jeffrey S. and Gorelick, Philip B. and Whelton, Andrew and Hunt, Barbara and Castillo, Majin and Gunawardhana, Lhanoo}, biburl = {https://www.bibsonomy.org/bibtex/2305ab8b387bcfaea0b1f775304fdb1e7/dianella}, citeulike-article-id = {14558375}, citeulike-linkout-0 = {http://dx.doi.org/10.1056/nejmoa1710895}, citeulike-linkout-1 = {http://www.nejm.org/doi/abs/10.1056/NEJMoa1710895}, day = 12, doi = {10.1056/nejmoa1710895}, interhash = {b13888956f295f39d172de7dff0d7f3d}, intrahash = {305ab8b387bcfaea0b1f775304fdb1e7}, journal = {N Engl J Med}, keywords = {citeulikeExport exampearl, rheumatology}, month = mar, number = 13, pages = {1200--1210}, posted-at = {2018-03-29 18:59:42}, priority = {2}, publisher = {Massachusetts Medical Society}, timestamp = {2019-03-31T01:16:26.000+0100}, title = {{Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout}}, url = {http://dx.doi.org/10.1056/nejmoa1710895}, volume = 378, year = 2018 }